XML 27 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
SHAREHOLDERS' EQUITY
6 Months Ended
Jun. 30, 2014
SHAREHOLDERS' EQUITY [Abstract]  
SHAREHOLDERS' EQUITY
NOTE 5:-
SHAREHOLDERS' EQUITY
 
 
1.
On November 26, 2013, the Company closed a firm commitment underwritten public offering of 2,852,000 ordinary shares (including 372,000 ordinary shares issued to the underwriter upon full exercise of its over-allotment option), at a public offering price of $7.00 per share. The net proceeds for the Company were approximately $18,000.

 
2.
During the six months ended June 30, 2014, 226,967 warrants were exercised into 226,967 of the Company's ordinary shares for a total amount of $109.

 
3.
The fair value for options granted in the periods presented is estimated at the date of grant using a Black-Scholes option-pricing model with the following weighted average assumptions:

   
Six months ended
June 30,
 
   
2014
   
2013
 
   
Unaudited
 
           
Risk free interest
    1.16 %     0.57 %
Dividend yields
    0 %     0 %
Volatility
    63 %     81 %
Expected life (in years)
    4       4  

 
4.
The following is a summary of the Company's stock options activity for the six months ended June 30, 2014:

   
Number
of options
(in thousands)
   
Weighted
Average exercise
price
   
Weighted-
average
remaining
contractual term
(in years)
   
Aggregate
 intrinsic value
 
   
Unaudited
 
                         
Outstanding at December 31, 2013
    1,715     $ 3.47              
Granted
    432       11.10              
Exercised
    (425 )     1.56              
Canceled or forfeited
    (17 )     7.36              
                             
Outstanding at June 30, 2014
    1,705     $ 5.85       3.79     $ 5,153  
                                 
Exercisable at June 30, 2014
    868     $ 2.59       2.30     $ 4,574  
                                 
Vested and expected to vest at June 30, 2014
    1,623     $ 5.64       3.70     $ 5,129  

 
5.
The weighted average fair value of options granted during the six months ended June 30, 2014 was $5.40.
 
 
6.
The following table shows the total stock-based compensation expense included in the interim consolidated statements of operations:

   
Six months ended
June  30,
 
   
2014
   
2013
 
   
Unaudited
 
             
Research and development
  $ 191     $ 132  
Selling and marketing
    298       88  
General and administrative
    188       86  
                 
Total stock-based compensation expense
  $ 677     $ 306